27. Many large integrated delivery networks have a common electronic medical record system… A researcher wants to determine if the clinical outcomes for a chronic disease over a three-year period are better… Which research methodology will achieve this goal?
Answer: C
Cohort study
A cohort study is the most appropriate methodology for determining clinical outcomes over a defined period, as it allows researchers to observe and compare outcomes in a specific group of individuals with a chronic disease over three years.
A) Randomized control trial
While a randomized control trial (RCT) is a strong methodology for establishing causality, it is typically used for testing interventions rather than observing natural outcomes over time. In this case, the research goal is focused on assessing clinical outcomes rather than evaluating the effect of a specific treatment, making RCT less suitable.
B) Case study
A case study provides an in-depth analysis of a single individual or a small group, which limits the ability to generalize findings across a larger population. This method is not designed for longitudinal comparisons and lacks the statistical power needed to assess clinical outcomes over a three-year period effectively.
C) Cohort study
Cohort studies are ideal for examining the natural progression of chronic diseases by following a group over time. They enable researchers to track changes in clinical outcomes within the same population, thus providing comprehensive insights into long-term health trends.
D) Pre/post-study
A pre/post-study design evaluates outcomes before and after an intervention but does not provide a comparative framework for assessing outcomes over time in a chronic disease population. This approach may overlook confounding factors that could influence the results, making it less robust for this specific research question.
Conclusion
The cohort study is definitively the correct choice for assessing clinical outcomes in a chronic disease over a three-year period, as it allows for the observation of changes in a specific population. In contrast, the other options lack the necessary framework to effectively evaluate long-term outcomes related to the disease in question.